WHO ICTRP trial
[89Zr]Df-IAB22M2C anti-CD8 minibody PET/CT imaging to assess the in vivo…
NL-OMON49545 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON49545 |
|---|---|
| Public title | [89Zr]Df-IAB22M2C anti-CD8 minibody PET/CT imaging to assess the in vivo distribution of CD8+ T-cells in COVID-19 patients. |
| Scientific title | [89Zr]Df-IAB22M2C anti-CD8 minibody PET/CT imaging to assess the in vivo distribution of CD8+ T-cells in COVID-19 patients. - PET/CT imaging to track CD8+ T-cells in COVID-19 patients. |
| Primary sponsor | Radboud Universitair Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | COVID-19; coronavirus infection;10047438;10037454;COVID-19; coronavirus infection |
| Interventions | ;[89Zr]Df-IAB22M2C;COVID-19;PET/CT |
| Registration date | Jun 28, 2021 |
| Target size | 20 |
| Secondary IDs | 2020-005984-29;NL76248.091.20 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: